Nicholas Galakatos, Director at Ophthotech Corp. (OPHT), sold 3,000 shares at $63.90 ($193K) on 2015-12-10, disclosed to the SEC on 2015-12-14.
Scheduled sale ($193k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.90 | 533 | $34K | 17.6% |
| 2 | $63.91 | 267 | $17K | 8.8% |
| 3 | $64.63 | 733 | $47K | 24.5% |
| 4 | $64.63 | 1,467 | $95K | 49.0% |
| Total | $64.44 avg | 3,000 | $193K | 100% |
| Filing → |
| FTSV | BUY | 2018-07-02 | $3.2M | — | Filing → |
| OPHT | SELL | 2016-01-13 | $197K | — | Filing → |
| OPHT | SELL | 2015-11-19 | $90K | — | Filing → |